NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • A Guide to What We Do
    • Activities during COVID-19
    • Strategic Partnership Board
    • Steering Committee
    • Promoting Equality, Diversity and Inclusion in Research
    • Current Vacancies
    • Contact Us
    • Stay in Touch
  • Research
        • OUR 20 RESEARCH THEMES

        • Antimicrobial Resistance and Modernising Microbiology
        • Cardiovascular
        • Clinical Informatics and Big Data
        • Diabetes and Metabolism
        • Gastroenterology and Mucosal Immunity
        • Genomic Medicine
        • Haematology and Stem Cells
        • Imaging
        • Molecular Diagnostics
        • Multi-Modal Cancer Therapies
        • Multi-Morbidity and Long-Term Conditions
        • Musculoskeletal
        • Neurological Conditions
        • Obesity, Diet and Lifestyle
        • Partnerships for Health, Wealth and Innovation
        • Respiratory
        • Stroke and Vascular Dementia
        • Surgical Innovation and Evaluation
        • Technology and Digital Health
        • Vaccines for Emerging and Endemic Diseases
        • Oxford Biomedical Research Centre activities during COVID-19
  • Patient & Public Involvement
    • Getting involved with research
    • Researcher Guidance
    • Post an opportunity for patient and public involvement
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Preparatory Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • What Can We Do For Your Organisation?
    • Who Do We Work With?
    • IP and Licensing
    • Contacts for Industry
  • Videos
  • News
  • Events

News

You are here: Home > Haematology and Stem Cells > Oxford Centre for Haematology launched

Oxford Centre for Haematology launched

10 January 2018 · Listed under Haematology and Stem Cells

Oxford Centre for HaematologyThe new Oxford Centre for Haematology has been launched with funding from the NIHR Oxford Biomedical Research Centre (BRC), bringing together University of Oxford researchers and clinicians from Oxford University Hospitals NHS Foundation Trust.

The aim of this new virtual centre is to bring people working in haematology together to improve the understanding and treatment of blood diseases and disorders, and to deliver the best available care to patients.

The centre will be hosted by the university’s Radcliffe Department of Medicine, and embedded within the Nuffield Division of Clinical Laboratory Sciences.

However, it will actively draw members from beyond the department with the aim of promoting integration between academic and clinical haematology programmes in the university and OUH and so capitalise on scientific opportunities to transform our understanding of haemopoiesis and blood diseases, and radically improve patient care.

The OCH will be led by Prof Paresh Vyas, (left) Professor of Haematology at the university and a Consultant Haematologist with the OUH, so ideally positioned to bridge the academic and clinical facets of this collaborative venture.

Prof Vyas is the Co-theme Lead for Haematology and Stem Cells, and the Interim Theme Lead for Molecular Diagnostics of the NIHR Oxford Biomedical Research Centre, whose funding has helped to make the OCH a reality.

The OCH builds on over 40 years of haematology research excellence in Oxford. From the pioneering work on globins led by Professor Sir David Weatherall, Prof John Clegg and Prof Doug Higgs, through to our current position of driving the largest blood cancer clinical trials programme in the UK, Oxford is a powerhouse of haematology research.

The centre will build on and enhance our understanding of blood cancers, ageing of the haemopoietic system and the links with inflammation and immunity.

It will also raise new funding for research, trials and implementation into clinical practice, alongside training the next generation of scientists and healthcare professionals.

Partnerships are at the heart of OCH – between researchers and clinicians, with industry and with patients – and it is expected that improved patient outcomes will arise from better integration of resources and ideas.

Find out more about the OCH.

The OCH will be hosting an Inaugural Symposium on 26 March. It will be an opportunity to learn about the centre‘s goals and research priorities. You can register here.

If you have any questions about OCH, please direct them to Julie Stevens.

← MDS Patient Support Group learn more about treatment of condition
Oxford medical researchers win prestigious national awards →

News

  • Lymph nodes reveal more about mechanisms of autoimmunity 14 June 2022
  • Conference aims to forge collaborations to tackle dementia 9 June 2022
  • Lung function device wins top chemistry Prize 8 June 2022
See full news archive

News Categories

Month Archives

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Oxford BRC on Social Media

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

  • Sitemap
  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2022 NIHR Oxford Biomedical Research Centre